{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:19:29Z","timestamp":1793017169458,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41431-017-0070-6","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T15:52:48Z","timestamp":1516895568000},"page":"758-764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical utility gene card for McArdle disease"],"prefix":"10.1038","volume":"26","author":[{"given":"Rhonda L.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Brull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Pinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"70_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/humu.22806","volume":"36","author":"G Nogales-Gadea","year":"2015","unstructured":"Nogales-Gadea G, Brull A, Santalla A, Andreu AL, Arenas J, Mart\u00edn MA, et al. McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum Mutat. 2015;36:669\u201378.","journal-title":"Hum Mutat"},{"key":"70_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1172\/JCI112794","volume":"79","author":"S Gautron","year":"1987","unstructured":"Gautron S, Daegelen D, Mennecier F, Dubocq D, Kahn A, Dreyfus J-C. Molecular mechanisms of McArdle\u2019s disease (muscle glycogen phosphorylase deficiency). J Clin Invest. 1987;79:275\u201381.","journal-title":"J Clin Invest"},{"key":"70_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.nmd.2011.07.002","volume":"21","author":"I Vieitez","year":"2011","unstructured":"Vieitez I, Teijeira S, Fernandez JM, San Millan B, Miranda S, Ortolano S, et al. Molecular and clinical study of McArdle\u2019s disease in a cohort of 123 European patients. Identification of 20 novel mutations. Neuromuscul Disord. 2011;21:817\u201323.","journal-title":"Neuromuscul Disord"},{"key":"70_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/humu.20649","volume":"29","author":"G Nogales-Gadea","year":"2008","unstructured":"Nogales-Gadea G, Rubio JC, Fernandez-Cadenas I, Garcia-Consuegra I, Lucia A, Cabello A, et al. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Hum Mutat. 2008;29:277\u201383.","journal-title":"Hum Mutat"},{"key":"70_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ncpneuro0913","volume":"4","author":"A Lucia","year":"2008","unstructured":"Lucia A, Nogales-Gadea G, P\u00e9rez M, Mart\u00edn MA, Andreu AL, Arenas J. McArdle disease: what do neurologists need to know? Nat Clin Pract Neurol. 2008;4:568\u201377.","journal-title":"Nat Clin Pract Neurol"},{"key":"70_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mus.21351","volume":"40","author":"AA Nadaj-Pakleza","year":"2009","unstructured":"Nadaj-Pakleza AA, Vincitorio CM, Lafor\u00eat P, Eymard B, Dion E, Teijeira S, et al. Permanent muscle weakness in McArdle disease. Muscle Nerve. 2009;40:350\u20137.","journal-title":"Muscle Nerve"},{"key":"70_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","volume":"83","author":"A Lucia","year":"2012","unstructured":"Lucia A, Ruiz JR, Santalla A, Nogales-Gadea G, Rubio JC, Garc\u00eda-Consuegra I, et al. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry. 2012;83:322\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/clinchem\/46.8.1198","volume":"46","author":"Z Zaman","year":"2000","unstructured":"Zaman Z, De Raedt S. Ischemic exercise testing in suspected McArdle disease. Clin Chem. 2000;46:1198\u20139.","journal-title":"Clin Chem"},{"key":"70_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ana.10263","volume":"52","author":"P Kazemi-Esfarjani","year":"2002","unstructured":"Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J. A nonischemic forearm exercise test for McArdle disease. Ann Neurol. 2002;52:153\u20139.","journal-title":"Ann Neurol"},{"key":"70_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/JSM.0b013e3180f6168c","volume":"17","author":"JL Mat\u00e9-Mu\u00f1oz","year":"2007","unstructured":"Mat\u00e9-Mu\u00f1oz JL, Moran M, P\u00e9rez M, Chamorro-Vi\u00f1a C, G\u00f3mez-Gallego F, Santiago C, et al. Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med. 2007;17:297\u2013303.","journal-title":"Clin J Sport Med"},{"key":"70_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.10725","volume":"54","author":"J Vissing","year":"2003","unstructured":"Vissing J, Haller RG. A diagnostic cycle test for McArdle\u2019s disease. Ann Neurol. 2003;54:539\u201342.","journal-title":"Ann Neurol"},{"key":"70_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-1-4160-2593-1.50008-5","volume-title":"Muscle Biopsy","author":"Victor Dubowitz","year":"2007","unstructured":"Dubowitz V, Sewry CA. Muscle biopsy: a practical approach. 3rd ed. Oxford: Elsevier; 2013."},{"key":"70_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/gim.2015.9","volume":"17","author":"M Castro De","year":"2015","unstructured":"De Castro M, Johnston J, Biesecker L. Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data. Genet Med. 2015;17:1002\u20136.","journal-title":"Genet Med"},{"key":"70_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0009-8981(95)06044-X","volume":"236","author":"H Sugie","year":"1995","unstructured":"Sugie H, Sugie Y, Ito M, Fukuda T, Nonaka I, Igarashi Y. Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle\u2019s disease): single-codon deletion in exon 17 is the predominant mutation. Clin Chim Acta. 1995;236:81\u20136.","journal-title":"Clin Chim Acta"},{"key":"70_CR15","first-page":"35","volume":"26","author":"S Mauro Di","year":"2007","unstructured":"Di Mauro S. Muscle glycogenoses: an overview. Acta Myol. 2007;26:35\u201341.","journal-title":"Acta Myol"},{"key":"70_CR16","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/brain\/awp065","volume":"132","author":"J Vissing","year":"2009","unstructured":"Vissing J, Duno M, Schwartz M, Haller RG. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease. Brain. 2009;132:1545\u201352.","journal-title":"Brain"},{"key":"70_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/00365517509095787","volume":"35","author":"J Bergstrom","year":"1975","unstructured":"Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest. 1975;35:609\u201316.","journal-title":"Scand J Clin Lab Invest"},{"key":"70_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nmd.2007.10.006","volume":"18","author":"JM Howell","year":"2008","unstructured":"Howell JM, Walker KR, Davies L, Dunton E, Everaardt A, Laing N, et al. Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle\u2019s disease: Expression and re-expression of glycogen phosphorylase. Neuromuscul Disord. 2008;18:248\u201358.","journal-title":"Neuromuscul Disord"},{"key":"70_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1212\/01.wnl.0000194212.31318.fc","volume":"66","author":"A Schroers","year":"2006","unstructured":"Schroers A, Kley R, Stachon A, Horvath R, Lochmuller H, Zange J, et al. Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency. Neurology. 2006;66:285\u20136.","journal-title":"Neurology"},{"key":"70_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nmd.2012.06.348","volume":"23","author":"KE Birch","year":"2013","unstructured":"Birch KE, Quinlivan RM, Morris GE. Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon. Neuromuscul Disord. 2013;23:43\u201351.","journal-title":"Neuromuscul Disord"},{"key":"70_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1242\/dmm.020230","volume":"8","author":"N Luna de","year":"2015","unstructured":"de Luna N, Brull A, Guiu JM, Lucia A, Martin MA, Arenas J, et al. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro. Dis Model Mech. 2015;8:467\u201372.","journal-title":"Dis Model Mech"},{"key":"70_CR22","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMoa031836","volume":"349","author":"J Vissing","year":"2003","unstructured":"Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle\u2019s disease. N Engl J Med. 2003;349:2503\u20139.","journal-title":"N Engl J Med"},{"key":"70_CR23","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/adc.2008.146548","volume":"79","author":"ST Andersen","year":"2008","unstructured":"Andersen ST, Vissing J. Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity. J Neurol Neurosurg Psychiatry. 2008;79:1359\u201363.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"70_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neulet.2005.08.026","volume":"391","author":"C Paradas","year":"2005","unstructured":"Paradas C, Fernandez-Cadenas I, Gallardo E, Llig\u00e9 D, Arenas J, Illa I, et al. Variable presentation of the clinical phenotype of McArdle\u2019s disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene. Neurosci Lett. 2005;391:28\u201331.","journal-title":"Neurosci Lett"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-017-0070-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-017-0070-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-017-0070-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:41:44Z","timestamp":1684618904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-017-0070-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1038\/s41431-017-0070-6","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"2 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}